03-11-2021, 08:08 PM
- Denmark has announced that it is to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford.
- The precaution comes “after reports of severe cases of blood clots in people who have been vaccinated with the COVID-19 vaccine from AstraZeneca.”
- “It is important to emphasize that we have not opted out of the AstraZeneca vaccine, but that we are putting it on hold,” the country’s National Board of Health said.
- The AstraZeneca-University of Oxford vaccine is being relied upon heavily in the U.K. and European Union’s immunization rollouts.
LONDON — Denmark announced Thursday it will temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford.
The Danish Health Authority said it would temporarily stop using the shot in its vaccination program as a precaution “after reports of severe cases of blood clots in people who have been vaccinated with the COVID-19 vaccine from AstraZeneca.”
“Against this background, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. At present, it cannot be concluded whether there is a link between the vaccine and the blood clots,” the health authority said in a statement.
It did not specify how many reports of blood clots there had been, or where they had originated.
- More -